Skip to content

Blue Owl Capital OBDC Issuance of common stock and replacement awards in connection with Oclaro acquisition

Issuance of common stock and replacement awards in connection with Oclaro acquisition at other companies

Life360, Inc. logo
Life360, Inc.LIF
$28.04M+2,704%
Blue Owl Capital logo
Blue Owl CapitalOBDC
$0-100%
Karman Holdings Inc. logo
Karman Holdings Inc.KRMN
$15.21M+424%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$0-100%
BGC Group, Inc. logo
BGC Group, Inc.BGC
$3.9M+10.8%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$232.53M+2,571%

Other financials

Income statement

See full
Net income-$24.4M-110%
EPS (diluted)-$0.05-110%

Balance sheet

See full
Cash & equivalents$455.4M-11.4%
Total debt$10.0B-2.0%
Total equity$7.2B-7.6%
Total assets$16.0B-12.8%

Cash flow

See full
Operating cash flow$967.4M+2,384%

Valuation

See full
Market cap$5.39B-26.2%

Returns & leverage

See full
Return on equity4.8%-4.7pp
Debt / equity1.4×+0.1×

Where this comes from

Reported directly by Blue Owl Capital in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable.

The official record: Blue Owl Capital’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Blue Owl Capital's issuance of common stock and replacement awards in connection with oclaro acquisition.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Blue Owl Capital's issuance of common stock and replacement awards in connection with oclaro acquisition?
Blue Owl Capital (OBDC) reported issuance of common stock and replacement awards in connection with oclaro acquisition of $0 in Q1 2026.
How has Blue Owl Capital's issuance of common stock and replacement awards in connection with oclaro acquisition changed year-over-year?
Blue Owl Capital's issuance of common stock and replacement awards in connection with oclaro acquisition decreased by 100.0% year-over-year, from $1.76B to $0.
What does issuance of common stock and replacement awards in connection with oclaro acquisition mean?
Represents the fair value of equity instruments issued as consideration for acquiring another business or portfolio. This metric quantifies the dilution impact and the strategic cost of inorganic expansion through stock-based acquisitions.